Senvelgo - direct healthcare professional communication (DHPC)

Velagliflozin L-proline monohydrate

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Senvelgo (velagliflozin) 15 mg/ml oral solution for cats: Known risk of diabetic ketoacidosis (DKA) in cats with diabetes mellitus associated with the use of the product

Key facts

• Medicine name:
  Senvelgo
• Active substance:
  Velagliflozin L-proline monohydrate
• Procedure number:
  EMEA/V/C/005972
• DHPC type:
  Adverse event
• Veterinary ATC codes:
  QA10BK90
• Species:
  Cats
• Dissemination date:
  19/07/2024